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Recuvyra	dosing	by	micro	pipette	
Alowing	Recuvyra	to	dry	
Hargreave	analgesia	test	after	1,	2	&	3	days	
Blood	sampling	at	2,	4,	8	24,	48	&	72	hrs.	
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Recuvyra, a transdermal fentanyl formulation for dogs, has 
shown to be able to sustain effective analgesia for four days. 
Such a drug would be welcome in rodent analgesia in order 
to avoid stress related to repeated parenteral administration. 
For this reason six rats were dosed with 0.014 mg/kg 
transdermal fentanyl (Recuvyra). The study included an 
untreated control group (n=6). All animals were exposed to 
the Hargreaves thermo-analgesic plantar test after 1, 2 & 3 
days and blood was sampled after 2, 4, 8, 24, 48 & 72 hours. 
Results & conclusion 
After 18 hrs. the plasma fentanyl concentration was below the 
threshold of 1.4 ng/ml and negligible below 0.3 ng/ml after 48 
& 72 hrs. 
There was no statistical significance in the thermic latencies 
between the test- and control rats in the Hargreaves test. 
Only mild side effects (pica eating) in the test group were 
observed within the first eight hours after administration. 
We concluded that transdermal fentanyl (Recuvyra) did not 
have the expected extended-release effect in rats.	
